Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase Agreement

  • Biogen Inc. BIIB has informed Karyopharm Therapeutics Inc KPTI that it has opted to terminate the companies' Asset Purchase Agreement dated January 24, 2018, as amended.
  • As per the agreement, Karyopharm sold rights of its oral Selective Inhibitor of Nuclear Export compound KPT-350 and certain related assets to Biogen.
  • KPTI received an upfront payment of $10 million in 2018 and was eligible to receive additional payments of up to $207 million based on the achievement by Biogen of future specified development and commercial milestones.
  • KPTI was also eligible to receive tiered royalty payments that reach low double-digits based on future net sales.
  • Due to the termination of the agreement, Karyopharm is now not entitled to any milestone payments or royalties. However, it has certain rights relating to the purchased assets upon termination of the agreement.
  • Price Action: KPTI shares are trading lower by 3.74% at $4.38 during the post-market session on Wednesday, and BIIB closed higher by 1.59% at $197.26.

Posted In: BriefsNewsPenny StocksSmall CapMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.